日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study

双特异性抗体治疗后B细胞淋巴瘤患者接受异基因造血干细胞移植巩固治疗:一项GETH-TC研究

Peña, Marta; Losi, Giulia; Navarro, Víctor; Qualls, David A; Crombie, Jennifer L; Mariotti, Jacopo; Bramanti, Stefania; Fabbri, Nicole; Serna, Ángel; Serroukh, Yasmina I M; Balaguer-Rosselló, Aitana; Van Der Poel, Marjolein W M; Hsu, Ya-Ting; Jiménez-Ubieto, Ana; McKinnely, Christopher; López-Corral, Lucía; Panizo, Carlos; Pérez-Simón, José Antonio; Rovira, Montserrat; Saldaña, Raquel; Kwon, Mi; Solano, Carlos; Valcárcel, David; Pascual-Cascón, María Jesús; Noriega, Víctor; Sanz, Jaime; Sánchez-Salinas, Andrés; Jurado, Manuel; Calbacho, Maria; Bento, Leyre; Albo López, Carmen; Perera, Maria; Heras, Inmaculada; Guerreiro, Manuel; Balsalobre, Pascual; Armand, Philippe; Sureda, Anna; Mussetti, Alberto

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

基于既往CD19靶向CAR-T细胞治疗史,评估tafasitamab和来那度胺治疗大B细胞淋巴瘤的疗效。

Merrill, Mwanasha H; Redd, Robert A; Lambert, Nicholas; Caimi, Paolo F; Pullarkat, Priyanka; Godby, Richard C; Bond, David A; Wehmeyer, Graham T; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J; Crombie, Jennifer L; Abramson, Jeremy S; Khurana, Arushi; Nowakowski, Grzegorz S; Maddocks, Kami; Rutherford, Sarah C; Kahl, Brad; Okwali, Michelle; Buege, Michael J; Batlevi, Connie L; Armand, Philippe; Salles, Gilles; Qualls, David A

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

一项关于商业用途的axicabtagene ciloleucel和lisocabtagene maraleucel在大B细胞淋巴瘤中的真实世界比较研究

Looka, Andrew; Qualls, David A; Matthews, Daniel; Redd, Robert A; Sakellis, Christopher; Duffy, Caitlyn; Dela Cruz, Jamie; Saucier, Anna; Armand, Philippe; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Parry, Erin M; Jacobson, Caron A

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

双重难治性和双重暴露慢性淋巴细胞白血病患者的特征和预后

Yoon, James T; Zhou, Yinglu; Mikhaleva, Mariia; Choi, Daniel S; Fernandes, Stacey M; Armand, Philippe; Bessnow, Amy C; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Odejide, Oreofe O; Parry, Erin M; Qualls, David A; Ryan, Christine E; Sekar, Aswin; Soumerai, Jacob D; Arnason, Jon; Tyekucheva, Svitlana; Davids, Matthew S; Brown, Jennifer R; Ahn, Inhye E

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Tafasitab 和来那度胺治疗大 B 细胞淋巴瘤:一项多中心回顾性研究的真实世界结果

Qualls, David A; Lambert, Nicholas; Caimi, Paolo F; Merrill, Mwanasha; Pullarkat, Priyanka; Godby, Richard C; Bond, David A; Wehmeyer, Graham T; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J; Crombie, Jennifer L; Abramson, Jeremy S; Khurana, Arushi; Nowakowski, Grzegorz S; Maddocks, Kami; Rutherford, Sarah C; Kahl, Brad; Okwali, Michelle; Buege, Michael J; Seshan, Venkatraman; Batlevi, Connie L; Salles, Gilles

Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance

淋巴细胞活化基因3在非小细胞肺癌中的表达:与临床病理特征及预后意义的相关性

Shepherd, Daniel J; Tabb, Elisabeth S; Kunitoki, Keiko; Zhang, M Lisa; Kem, Marina; Barth, Jaimie; Qualls, David A; Mooradian, Meghan J; Gainor, Justin F; Mino-Kenudson, Mari; Hung, Yin P

Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1.

野生型人类 SOD1 的特征限制了其与小鼠 G86R Sod1 错误折叠聚集体的相互作用

Qualls David A, Prudencio Mercedes, Roberts Brittany L T, Crosby Keith, Brown Hilda, Borchelt David R